glp 1 and iron absorption Absorption: Molecular Pathophysiological Aspects Glucagon-like peptide-1 receptor: mechanisms and

A study of patients with non-alcoholic fatty liver disease (NAFLD) revealed that giving 300 mg of glutathione daily for four months resulted in significant reductions in elevated ALT (an enzyme associated with liver damage), triglycerides, and ferritin

In type 2 diabetes, postprandial GLP-1 secretion may be reduced , leading to an impaired insulin response

Clinical fit: Whether peptide therapy fits the patients goals, medical history, medications, and risk profile

They enhance insulin secretion in response to food intake, suppress glucagon release (reducing excess glucose production by the liver), and slow gastric emptying, thereby promoting satiety and reducing appetite